Roxadustat and the Interpretation of Non-Inferiority

from Journal of the American Society of Nephrology (JASN) · host American Society of Nephrology

In this Podcast, JASN EIC, Josie Briggs, discusses a clinical trial from the April issue on roxadustat in dialysis patients with Magdalene Assimon. Dr. Assimon explains the interpretation of the finding that roxadustat is non-inferior to epoetin alpha.

Episode metadata supplied by the publisher feed · Published Apr 11, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Roxadustat and the Interpretation of Non-Inferiority

0:00 16:01

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Journal of the American Society of Nephrology (JASN)?

This episode is 16 minutes long.

When was this Journal of the American Society of Nephrology (JASN) episode published?

This episode was published on April 11, 2022.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Journal of the American Society of Nephrology (JASN) episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!